Point72 Asia (Singapore) Pte. Ltd. Nkarta, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Nkarta, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 6,270 shares of NKTX stock, worth $11,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,270Holding current value
$11,724% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
58.1MCall Options Held
2MPut Options Held
58.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$20.2 Million0.38% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$13.2 Million0.66% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.59 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.05 Million2.96% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.67 Million0.46% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $91M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...